Advertisement

Polycaprolactone for the Face

  • Pierre Nicolau
Chapter
  • 15 Downloads

Abstract

The product is a sterile, totally bioresorbable implant, whose principle components are polycaprolactone (PCL) microspheres suspended in a gel carrier of carboxymethyl cellulose. Microspheres have a size range of 25–50 μm, and it should be injected with a 27G needle or a 27G or 25G cannula. It comes in a range of four products, the only difference being the time needed for bulk hydrolysis, 1, 2, 3, or 4 years, allowing for a choice of duration according to the different needs for cosmetic or reconstructive purposes. It may be injected either deep, on the pre-periosteal plane, or superficially, in the hypodermis, as all particulate filler injections should be avoided into the dermis and muscles. The major capacity of collagen stimulation makes it suitable either for volume compensation or for major production of collagen type I, the major component of collagen in normal skin (Nicolau, Plast reconstr Surg 119:2271–2286, 2007).

Keywords

Polycaprolactyone Dermal fillers Collagen stimulation Skin booster Facial volume 

References

  1. 1.
    Nicolau PJ. Long lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstr Surg. 2007;119(7):2271–86.CrossRefGoogle Scholar
  2. 2.
    Stocks D, Sundaram H, Michaels J, Durrani MJ, Wortzman MS, Nelson DB. Rheological evaluation of the physical properties of hyaluronic acid dermal fillers. J Drugs Dermatol. 2011;10:974–80.Google Scholar
  3. 3.
    De Melo F, Marijnissen-Hofsté JM. Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine. Dermatol Ther. 2012;2(1):13–23.CrossRefGoogle Scholar
  4. 4.
    Pitt CG. Poly (e-caprolactone) and its copolymers. In: Chassin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Dekker; 1990. p. 71–119.Google Scholar
  5. 5.
    Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27:1735–40.CrossRefGoogle Scholar
  6. 6.
    Nicolau PJ, Marijnissen-Hofsté JM. Neocollagenesis after injection of a polycaprolactone based dermal filler in a rabbit. Eur J Aesthetic Med Dermatol. 2013;3:19–26.Google Scholar
  7. 7.
    Goldberg DJ, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable ply-L-lactic acid. Dermatol Surg. 2013;39(6):1–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Pierre Nicolau
    • 1
  1. 1.Pierre Nicolau Clinic of Plastic SurgeryFigueras (Girona)Spain

Personalised recommendations